Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma is a research paper published in European Respiratory Journal (2021). On theSindex it has a DataRank of 1.4. It has been cited 29 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0.847
From 22 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
Sanofi
Regeneron Pharmaceuticals
MeSH Terms